{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:10:53Z","timestamp":1790104253401,"version":"4.0.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:p>We investigated the frequency, histopathologic, and immunohistochemical characteristics of tubal involvement in uterine serous carcinoma (USC) and aimed to clarify the relationship between \u201cserous tubal intraepithelial carcinoma (STIC)\u201d and USC in these cases. Cases of USC with complete tubal examination were prospectively collected and reviewed for the presence of tubal involvement. Immunohistochemical analysis for p53 and WT1 was performed on the endometrial and tubal tumor in cases with tubal involvement. Of 161 USC cases (pure USC or a component of a mixed carcinoma or a carcinosarcoma), 32 (20%) showed tubal involvement (unilateral: n=19; bilateral: n=13). The uterine tumors in cases with tubal involvement showed a trend toward increased likelihood of deep myometrial and lymphovascular invasion (LVI) compared with those without tubal involvement. The tubal fimbriae were involved in 15\/32 cases. Tubal involvement was mucosal in 30\/32 cases, mural in 14\/32, serosal in 5\/32, invasive in 22\/32, and there was LVI in the tube in 13\/32. STIC-like features were seen in 17\/32 cases (7 as the only pattern of involvement, 9 with associated invasive carcinoma, and 5 with LVI). Immunostaining showed complete concordance of p53 and WT1 between the endometrial and tubal tumors in 26\/32 cases, the majority being WT1 negative or only focally positive (19\/26), and all exhibiting mutation-type p53 staining. On the basis of the histologic and immunohistochemical features, the tubal tumor was considered to represent metastatic USC in 26\/32 cases, most likely metastatic USC in 2\/32 cases, an independent tubal primary tumor in 3\/32 cases, and to be of uncertain origin in the 1 remaining case. STIC-like lesions were considered to represent metastatic USC in 12\/17 cases, most likely metastatic USC in 2\/17 cases, an independent tubal primary in 2\/17 cases, and of uncertain origin in the 1 remaining case. Tubal involvement, including STIC-like lesions, is seen in one fifth of USC when the tubes are examined in their entirety. The tubal involvement is metastatic in the vast majority of cases. Immunohistochemical studies assist, in most cases, in confirming the metastatic nature of the tubal disease. Consideration should be given to completely examining the fallopian tubes in apparent stage I or II USCs, as this will result in upstaging in a significant minority of cases.<\/jats:p>","DOI":"10.1097\/pas.0000000000000757","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T11:55:41Z","timestamp":1477137341000},"page":"161-170","source":"Crossref","is-referenced-by-count":73,"title":["Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma"],"prefix":"10.1097","volume":"41","author":[{"given":"Friedrich","family":"Kommoss","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Faruqi","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Barts NHS Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lamshang Leen","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Barts and the London NHS Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Barts and the London NHS Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisa","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital, Leeds"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006254-199102000-00014","article-title":"Uterine papillary serous carcinoma: a review","volume":"46","author":"Dunton","year":"1991","journal-title":"Obstet Gynecol Surv"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases","volume":"28","author":"Darvishian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/path.4056","article-title":"Use of mutation profiles to refine the classification of endometrial carcinomas","volume":"228","author":"McConechy","year":"2012","journal-title":"J Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-199206000-00008","article-title":"Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features","volume":"16","author":"Sherman","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PGP.0000000000000270","article-title":"Adopting a uniform approach to site assignment in tubo-ovarian high-grade serous carcinoma: the time has come","volume":"35","author":"Singh","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAT.0000000000000291","article-title":"The secondary Mullerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters","volume":"47","author":"Singh","year":"2015","journal-title":"Pathology"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/his.12651","article-title":"Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum","volume":"67","author":"Singh","year":"2015","journal-title":"Histopathology"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000352","article-title":"Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series","volume":"39","author":"Morrison","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/PAS.0000000000000293","article-title":"Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia","volume":"39","author":"Rabban","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/modpathol.2013.212","article-title":"Mullerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocol","volume":"27","author":"Mingels","year":"2014","journal-title":"Mod Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0000000000000109","article-title":"Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma","volume":"34","author":"Tolcher","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/PGP.0b013e3181c1158e","article-title":"Coexisting serous carcinoma of the endometrium and the fallopian tube","volume":"29","author":"Stewart","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/modpathol.2014.76","article-title":"Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma","volume":"28","author":"Jia","year":"2015","journal-title":"Mod Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R22-20230922","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","author":"K\u00f6bel","year":"2016","journal-title":"J Pathol: Clin Res"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","article-title":"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma","volume":"119","author":"Pennington","year":"2013","journal-title":"Cancer"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.humpath.2014.05.009","article-title":"The frequency and significance of WT-1 expression in serous endometrial carcinoma","volume":"45","author":"Hedley","year":"2014","journal-title":"Hum Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2559.2009.03390.x","article-title":"WT1, p53 and hormone receptor expression in uterine serous carcinoma","volume":"55","author":"Hirschowitz","year":"2009","journal-title":"Histopathology"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.pgp.0000179614.47838.82","article-title":"Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis","volume":"25","author":"Snyder","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/PAS.0b013e318282da7f","article-title":"Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis","volume":"37","author":"Bijron","year":"2013","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201702000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:17:24Z","timestamp":1695421044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201702000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000757","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}